ENTRY       D03250                      Drug
NAME        Insulin glargine (USAN/INN);
            Insulin glargine (genetical recombination) (JP18);
            Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN);
            Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN);
            Lantus (TN)
PRODUCT     BASAGLAR (Eli Lilly and Company)
            INSULIN GLARGINE (A-S Medication Solutions)
            INSULIN GLARGINE (Biocon Biologics)
            INSULIN GLARGINE (Mylan Specialty L.P.)
            INSULIN GLARGINE (Sanofi-Aventis U.S. LLC)
            INSULIN GLARGINE (Winthrop U.S.)
            INSULIN GLARGINE (Winthrop U.S.)
            INSULIN GLARGINE (sanofi-aventis U.S. LLC)
            INSULIN GLARGINE (sanofi-aventis U.S. LLC)
            INSULIN GLARGINE SOLOSTAR (A-S Medication Solutions)
            LANTUS (A-S Medication Solutions)
            LANTUS SOLOSTAR (A-S Medication Solutions)
            LANTUS SOLOSTAR (A-S Medication Solutions)
            REZVOGLAR (Eli Lilly and Company)
            REZVOGLAR KWIKPEN (A-S Medication Solutions)
            SEMGLEE (Biocon Biologics)
            SEMGLEE (Mylan Specialty L.P.)
            TOUJEO (A-S Medication Solutions)
            TOUJEO MAX (A-S Medication Solutions)
FORMULA     C267H404N72O78S6
EXACT_MASS  6058.8184
MOL_WEIGHT  6062.8903
SEQUENCE    (A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
            Gln Leu Glu Asn Tyr Cys Gly
            (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
            Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr
            Arg Arg
            (Disulfide bridge: A6-A11, A7-B7, A20-B19)
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG01636  Insulin preparation
              DG01797  Insulin analog, long-acting
            Metabolizing enzyme inducer
             DG01637  CYP1A2 inducer
REMARK      Therapeutic category: 2492
            ATC code: A10AE04
            Product: D03250<JP/US>
            Product (mixture): D11034<JP/US>
EFFICACY    Antidiabetic, Insulin receptor agonist
  DISEASE   Diabetes mellitus [DS:H00408 H00409]
TARGET      INSR (CD220) [HSA:3643] [KO:K04527]
  PATHWAY   hsa04910(3643)  Insulin signaling pathway
            hsa04930(3643)  Type II diabetes mellitus
INTERACTION CYP induction: CYP1A2 [HSA:1544]
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10A INSULINS AND ANALOGUES
                A10AE Insulins and analogues for injection, long-acting
                 A10AE04 Insulin glargine
                  D03250  Insulin glargine (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Insulins
               Insulin, Long-acting
                Insulin Glargine
                 D03250  Insulin glargine (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D03250  Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP18); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01636  Insulin preparation
               DG01797  Insulin analog, long-acting
                D03250  Insulin glargine
             Metabolizing enzyme inducer
              DG01637  CYP1A2 inducer
               D03250  Insulin glargine
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01636  Insulin preparation
               D03250  Insulin glargine
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                INSR (CD220)
                 D03250  Insulin glargine (USAN/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D03250  Insulin glargine (genetical recombination)
              D03250  Insulin glargine (genetical recombination) injection
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D03250
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D03250
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D03250
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D03250
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03250
DBLINKS     CAS: 160337-95-1
            PubChem: 17397403
            NIKKAJI: J2.173.686D
///
